Dezhan Healthcare Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Wei Liu

Chief Executive Officer (CEO)

CN¥4.0m

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	7.7yrs
Participación del CEO	0.2%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	2.8yrs

Actualizaciones recientes de la dirección

Recent updates

We Like The Quality Of Dezhan Healthcare's (SZSE:000813) Earnings

Apr 18

CEO

Wei Liu (54 yo)

7.7yrs

Permanencia

CN¥3,980,000

Compensación

Mr. Wei Liu is Co-Chairman & GM of Dezhan Healthcare Company Limited from October 28, 2016.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Wei Liu	Co-Chairman & GM	7.7yrs	CN¥3.98m	0.23% CN¥ 11.3m
Weihong Sun	Independent Director	2.8yrs	CN¥180.00k	sin datos
Bin Wu	Independent Director	2.8yrs	CN¥180.00k	sin datos
Hailin Yan	Non-Independent Director	2.8yrs	sin datos	sin datos
Zheming Wei	Chairman	7.7yrs	sin datos	0.021% CN¥ 1.0m
Feng Han	Director	2.1yrs	sin datos	sin datos
Sinian Chou	Non-Independent Director	2.8yrs	CN¥60.00k	sin datos
Xin An Wang	Independent Director	2.8yrs	sin datos	sin datos
Ping Li	Employee Supervisor	2.8yrs	sin datos	sin datos

2.8yrs

Permanencia media

54yo

Promedio de edad

Junta con experiencia: La junta directiva de 000813 no se considera experimentada (2.7 años de permanencia promedio), lo que sugiere una nueva junta directiva.

Dezhan Healthcare Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Dezhan Healthcare Company Limited, Annual General Meeting, May 08, 2024

High number of new and inexperienced directors

Recent updates

We Like The Quality Of Dezhan Healthcare's (SZSE:000813) Earnings

Full year 2023 earnings released: EPS: CN¥0.038 (vs CN¥0.021 loss in FY 2022)

Dezhan Healthcare Company Limited, Annual General Meeting, May 08, 2024

Dezhan Healthcare Company Limited to Report Q1, 2024 Results on Apr 25, 2024

Dezhan Healthcare Company Limited to Report Fiscal Year 2023 Results on Apr 12, 2024

Third quarter 2023 earnings released: EPS: CN¥0.033 (vs CN¥0 in 3Q 2022)

Dezhan Healthcare Company Limited to Report Q3, 2023 Results on Oct 26, 2023

Second quarter 2023 earnings released: CN¥0.004 loss per share (vs CN¥0.016 profit in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.001 (vs CN¥0.014 in 1Q 2022)

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0 (vs CN¥0.01 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.016 (vs CN¥0.017 in 2Q 2021)

Full year 2021 earnings: EPS and revenues miss analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.01 (vs CN¥0.026 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.017 (vs CN¥0.041 in 2Q 2020)

Dezhan Healthcare Company Limited Approves Final Dividend Implementation Plan (A Shares) for 2020, Payable on June 1, 2021

Dezhan Healthcare Company Limited Announces the Profit Distribution Proposal for 2020

First quarter 2021 earnings released: EPS CN¥0.029 (vs CN¥0.041 in 1Q 2020)

Investor sentiment improved over the past week

New 90-day low: CN¥3.98

Investor sentiment deteriorated over the past week

New 90-day low: CN¥5.85

Dezhan Healthcare's Controlling Shareholder Plans to Sell Stake in the Company

New 90-day high: CN¥6.85

Third quarter earnings released

New 90-day low: CN¥6.05

First half earnings released

Dezhan Healthcare Company Limited to Report First Half, 2020 Results on Aug 29, 2020

Dezhan Healthcare Company Limited (SZSE:000813) completed the acquisition of 70% stake in Beijing Changjiang Mai Medical Technology Co., Ltd from Dai Yanzhen.

CEO

Permanencia

Compensación

Miembros de la Junta

Permanencia media

Promedio de edad